Ibalizumab
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
HIV-1 Non Group-M Phenotypic Susceptibility to Ibalizumab.
Journal: Journal of medical virology
Published: September 02, 2025
Combined Use of Ibalizumab and Lenacapavir for the Treatment of Multidrug-resistant HIV-1: A Case Series.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 23, 2025
Switch from Ibalizumab to Lenacapavir in a Rescue Regimen for a Heavily Treatment-Experienced (HTE) Patient with Multidrug-Resistant (MDR) HIV-1 Infection.
Journal: International journal of molecular sciences
Published: June 12, 2025
Ibalizumab plus an optimized background regimen in treatment-experienced patients infected with multidrug resistant HIV-1: A phase 3, multicenter, expanded access study.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 04, 2025
Long-acting cabotegravir/rilpivirine, lenacapavir, and ibalizumab use among persons with HIV-1 viremia at a Ryan White-funded clinic in the urban U.S. South.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 29, 2025
PRESTIGIO RING: "A 28-year-old highly treatmentexperienced man with vertical HIV infection on ibalizumab therapy: ART simplification perspectives".
Journal: The new microbiologica
Published: November 19, 2024
Investigating the combination of Temsavir and entry inhibitors on HIV replication: Synergistic and antagonistic effects observed against various R5-tropic envelopes.
Journal: Virology
Published: October 30, 2024
Emerging integrase resistance in an international perinatal virtual clinic.
Journal: AIDS (London, England)
Published: September 03, 2024
US cost-utility model of lenacapavir plus optimized background regimen (OBR) vs fostemsavir plus OBR and ibalizumab plus OBR for people with HIV with multidrug resistance.
Journal: Journal of managed care & specialty pharmacy
Published: August 30, 2024
A Narrative Review of Novel Agents for Managing Heavily Treatment-Experienced People Living With HIV.
Journal: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
Published: August 19, 2024
Expanding Treatment Opportunities: Reviewing the Current State of Injectable Antiretrovirals for Treatment of HIV.
Journal: Infectious diseases and therapy
Published: July 31, 2024
Strategic use of salvage long-acting antiretrovirals in the setting of resistance.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: July 24, 2024
Last Updated: 04/28/2026